Actively Recruiting
Breast Cancer Screening Decision Aid: A Survey-based Comparison of Video and Written Formats
Led by Yale University · Updated on 2026-05-04
300
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
Y
Yale University
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating two types of decision aids to help women aged 75 and older make informed choices about breast cancer screening. This study compares a video-based decision aid to a written decision aid, focusing on how these tools affect women's intentions to continue screening, their readiness to decide, and their knowledge about screening. The study is conducted through an online survey platform and includes women who have been previously screened and have no history of breast cancer. Participants are randomly assigned to one of two groups. One group views a video under 4 minutes long that explains the screening decision, including potential benefits and risks with specific details. The other group reads a written electronic document covering the same information. Both groups answer questions before and after receiving their respective decision aids to assess changes. Participants complete surveys online that measure their decisional conflict, intention to screen, knowledge about breast cancer screening, and understanding of overdiagnosis. These assessments happen at baseline and immediately after the intervention, taking about 20 minutes total. The study is single-masked and aims to collect data on how each decision aid impacts decision-making regarding mammography screening in older women.
CONDITIONS
Brief Title
Breast Cancer Screening Decision Aid
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 75 years or older
- No prior history of breast cancer or ductal carcinoma in situ
- Have been screened for breast cancer at least once before
- English-speaking
- Able to complete an online survey
- Did not opt out of participation
You will not qualify if you...
- Prior history of breast cancer or ductal carcinoma in situ
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or online)
Duration - Approximately 20 minutes
Participants receive either a video or a written decision aid about breast cancer screening, including the potential benefits and risks. Participants answer questions before and immediately after viewing the decision aid.
1 visit (in-person or online)
Trial Site Locations
Total: 1 location
1
Yale School of Medicine
New Haven, Connecticut, United States, 06511
Actively Recruiting
Research Team
I
Ilana Richman, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here